Fig. 2: Sex- and age- adjusted difference (%) of symptoms lasting over 12 weeks between seropositive and seronegative children, December- February 2022, Geneva, Switzerland. | Nature Communications

Fig. 2: Sex- and age- adjusted difference (%) of symptoms lasting over 12 weeks between seropositive and seronegative children, December- February 2022, Geneva, Switzerland.

From: A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents

Fig. 2

Sample size: 79 children and adolescents whom experienced symptoms lasting over 12 week. The colored dots refer to types of symptoms, as presented in the legend. Data are presented as mean values of the differences between seropositive and seronegative children with +/−Standard Error of the Mean (SEM), illustrated by the error bars.

Back to article page